Serum calprotectin as a novel biomarker for severity of COVID-19 disease.
Tezcan KayaSelcuk YaylacıAhmet Nalbantİlhan YıldırımHavva KocayigitErdem ÇoklukMehmet Ramazan ŞekeroğluMehmet KöroğluErtugrul GuçluPublished in: Irish journal of medical science (2021)
These findings demonstrate that serum calprotectin level seems to be a useful biomarker that can predict the severity of COVID-19 disease. Serum calprotectin is a significant predictor of ICU requirement in patients with COVID-19.